Bioequivalence Study of 300 mg Gabapentin
Clinical trial NCT01738893 · COMPLETED
Trial details
- NCT number
- NCT01738893
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-14
- Primary completion
- 2011-01-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.